Clinical Trial Update: An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment [Phase 4]

View source ↗

Summary

An open-label, non-randomized Phase 4 trial in subjects with varying degrees of renal impairment (mild, moderate, severe, or no impairment) was completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: ApoPharma | Conditions: Renal Impairment | Phase 4 | Status: COMPLETED | Results posted: 2014-08-26